APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Growth and Trends Forecast to 2032

23 December 2025110 pages

Choose your research edition.

Industry ResearchChronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) include Abbott, Takeda, Fresenius, Amgen, Abbvie, Vifor, Spectrum, Shield and Sanofi Genzyme, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Company

Abbott

Takeda

Fresenius

Amgen

Abbvie

Vifor

Spectrum

Shield

Sanofi Genzyme

OPKO

Novadiol

Japan Tobacco Company

Daiichi-Sankyo

Astellas

Ardelyx

Akebia

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type

Maintain Blood Calcium Levels

Control Hyperphosphatemia

Control PTH Level

Correct Acidosis

Others

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Retail Pharmacies

Others

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Maintain Blood Calcium Levels Table 2. Major Company of Control Hyperphosphatemia Table 3. Major Company of Control PTH Level Table 4. Major Company of Correct Acidosis Table 5. Major Company of Others Table 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type (2021-2026) Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (US$ Million) Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type (2021-2026) Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2021-2026) & (US$/kg) Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2027-2032) & (tons) Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type (2027-2032) Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2027-2032) & (US$ Million) Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type (2027-2032) Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2027-2032) & (US$/kg) Table 17. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 18. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 20. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 22. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 24. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 26. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (US$ Million) Table 27. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends Table 28. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Drivers Table 29. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Opportunities and Challenges Table 30. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Restraints Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2021-2026) Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2021-2026) & (tons) Table 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Company (2021-2026) Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Price by Company (2021-2026) & (US$/kg) Table 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Major Company Production Sites and Headquarters Table 38. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Company, Product Type & Application Table 39. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026) & (tons) Table 44. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Region (2021-2026) Table 45. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026) & (US$ Million) Table 46. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Region (2021-2026) Table 47. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 48. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2027-2032) & (tons) Table 49. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Region (2027-2032) Table 50. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2027-2032) & (US$ Million) Table 51. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Region (2027-2032) Table 52. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 53. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 55. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application (2021-2026) Table 56. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (US$ Million) Table 57. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application (2021-2026) Table 58. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2021-2026) & (US$/kg) Table 59. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2027-2032) & (tons) Table 60. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application (2027-2032) Table 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2027-2032) & (US$ Million) Table 62. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application (2027-2032) Table 63. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2027-2032) & (US$/kg) Table 64. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 65. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 67. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 69. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 71. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 73. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (US$ Million) Table 74. Abbott Company Information Table 75. Abbott Business Overview Table 76. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 78. Abbott Recent Development Table 79. Takeda Company Information Table 80. Takeda Business Overview Table 81. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 83. Takeda Recent Development Table 84. Fresenius Company Information Table 85. Fresenius Business Overview Table 86. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 88. Fresenius Recent Development Table 89. Amgen Company Information Table 90. Amgen Business Overview Table 91. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 93. Amgen Recent Development Table 94. Abbvie Company Information Table 95. Abbvie Business Overview Table 96. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 98. Abbvie Recent Development Table 99. Vifor Company Information Table 100. Vifor Business Overview Table 101. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 103. Vifor Recent Development Table 104. Spectrum Company Information Table 105. Spectrum Business Overview Table 106. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 108. Spectrum Recent Development Table 109. Shield Company Information Table 110. Shield Business Overview Table 111. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 113. Shield Recent Development Table 114. Sanofi Genzyme Company Information Table 115. Sanofi Genzyme Business Overview Table 116. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 117. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 118. Sanofi Genzyme Recent Development Table 119. OPKO Company Information Table 120. OPKO Business Overview Table 121. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 122. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 123. OPKO Recent Development Table 124. Novadiol Company Information Table 125. Novadiol Business Overview Table 126. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 127. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 128. Novadiol Recent Development Table 129. Japan Tobacco Company Company Information Table 130. Japan Tobacco Company Business Overview Table 131. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 132. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 133. Japan Tobacco Company Recent Development Table 134. Daiichi-Sankyo Company Information Table 135. Daiichi-Sankyo Business Overview Table 136. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 137. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 138. Daiichi-Sankyo Recent Development Table 139. Astellas Company Information Table 140. Astellas Business Overview Table 141. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 142. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 143. Astellas Recent Development Table 144. Ardelyx Company Information Table 145. Ardelyx Business Overview Table 146. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 147. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 148. Ardelyx Recent Development Table 149. Akebia Company Information Table 150. Akebia Business Overview Table 151. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 152. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 153. Akebia Recent Development Table 154. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 155. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 156. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2026) Table 157. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032) & (tons) Table 158. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Country (2027-2032) Table 159. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026) & (US$ Million) Table 161. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country (2021-2026) Table 162. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Country (2027-2032) Table 164. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 165. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 166. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2026) Table 167. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032) & (tons) Table 168. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Country (2027-2032) Table 169. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026) & (US$ Million) Table 171. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country (2021-2026) Table 172. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 176. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2026) Table 177. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032) & (tons) Table 178. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026) & (US$ Million) Table 181. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country (2021-2026) Table 182. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Country (2027-2032) Table 184. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 185. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 186. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2026) Table 187. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032) & (tons) Table 188. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Country (2027-2032) Table 189. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026) & (US$ Million) Table 191. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country (2021-2026) Table 192. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 196. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2026) Table 197. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032) & (tons) Table 198. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country (2021-2026) Table 202. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Forecast by Country (2027-2032) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List Table 207. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Image Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2021-2032) & (tons) Figure 5. Maintain Blood Calcium Levels Image Figure 6. Global Maintain Blood Calcium Levels Sales YoY Growth (2021-2032) & (tons) Figure 7. Control Hyperphosphatemia Image Figure 8. Global Control Hyperphosphatemia Sales YoY Growth (2021-2032) & (tons) Figure 9. Control PTH Level Image Figure 10. Global Control PTH Level Sales YoY Growth (2021-2032) & (tons) Figure 11. Correct Acidosis Image Figure 12. Global Correct Acidosis Sales YoY Growth (2021-2032) & (tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type 2025 VS 2032 Figure 17. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type in 2025 Figure 18. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type in 2025 Figure 19. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type in 2025 Figure 20. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type in 2025 Figure 23. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (tons) Figure 31. Drug Stores Image Figure 32. Global Drug Stores Sales YoY Growth (2021-2032) & (tons) Figure 33. Online Pharmacies Image Figure 34. Global Online Pharmacies Sales YoY Growth (2021-2032) & (tons) Figure 35. Retail Pharmacies Image Figure 36. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (tons) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 39. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application 2025 VS 2032 Figure 41. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application in 2025 Figure 42. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application in 2025 Figure 43. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application in 2025 Figure 44. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application in 2025 Figure 47. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application in 2025 Figure 51. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 60. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 64. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 68. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Maintain Blood Calcium Levels
  • Control Hyperphosphatemia
  • Control PTH Level
  • Correct Acidosis
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Abbott
  • Takeda
  • Fresenius
  • Amgen
  • Abbvie
  • Vifor
  • Spectrum
  • Shield
  • Sanofi Genzyme
  • OPKO
  • Novadiol
  • Japan Tobacco Company
  • Daiichi-Sankyo
  • Astellas
  • Ardelyx
  • Akebia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Type
  6. 1.3.1 Maintain Blood Calcium Levels
  7. 1.3.2 Control Hyperphosphatemia
  8. 1.3.3 Control PTH Level
  9. 1.3.4 Correct Acidosis
  10. 1.3.5 Others
  11. 1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type
  12. 1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends
  2. 2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Drivers
  3. 2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Opportunities and Challenges
  4. 2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2026)
  2. 3.2 Global Top Players by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2021-2026)
  3. 3.3 Global Top Players by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (2021-2026)
  4. 3.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Major Company Production Sites & Headquarters
  6. 3.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Company, Product Type & Application
  7. 3.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Tier 1, Tier 2, and Tier 3
4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Regional Status and Outlook
  1. 4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historic Market Size by Region
  3. 4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Market Size by Region
  7. 4.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application
  1. 5.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Retail Pharmacies
  6. 5.1.5 Others
  7. 5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application
  8. 5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Fresenius
  14. 6.3.1 Fresenius Company Information
  15. 6.3.2 Fresenius Business Overview
  16. 6.3.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  18. 6.3.5 Fresenius Recent Developments
  19. 6.4 Amgen
  20. 6.4.1 Amgen Company Information
  21. 6.4.2 Amgen Business Overview
  22. 6.4.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  24. 6.4.5 Amgen Recent Developments
  25. 6.5 Abbvie
  26. 6.5.1 Abbvie Company Information
  27. 6.5.2 Abbvie Business Overview
  28. 6.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  30. 6.5.5 Abbvie Recent Developments
  31. 6.6 Vifor
  32. 6.6.1 Vifor Company Information
  33. 6.6.2 Vifor Business Overview
  34. 6.6.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  36. 6.6.5 Vifor Recent Developments
  37. 6.7 Spectrum
  38. 6.7.1 Spectrum Company Information
  39. 6.7.2 Spectrum Business Overview
  40. 6.7.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  42. 6.7.5 Spectrum Recent Developments
  43. 6.8 Shield
  44. 6.8.1 Shield Company Information
  45. 6.8.2 Shield Business Overview
  46. 6.8.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  48. 6.8.5 Shield Recent Developments
  49. 6.9 Sanofi Genzyme
  50. 6.9.1 Sanofi Genzyme Company Information
  51. 6.9.2 Sanofi Genzyme Business Overview
  52. 6.9.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  54. 6.9.5 Sanofi Genzyme Recent Developments
  55. 6.10 OPKO
  56. 6.10.1 OPKO Company Information
  57. 6.10.2 OPKO Business Overview
  58. 6.10.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  60. 6.10.5 OPKO Recent Developments
  61. 6.11 Novadiol
  62. 6.11.1 Novadiol Company Information
  63. 6.11.2 Novadiol Business Overview
  64. 6.11.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  66. 6.11.5 Novadiol Recent Developments
  67. 6.12 Japan Tobacco Company
  68. 6.12.1 Japan Tobacco Company Company Information
  69. 6.12.2 Japan Tobacco Company Business Overview
  70. 6.12.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  72. 6.12.5 Japan Tobacco Company Recent Developments
  73. 6.13 Daiichi-Sankyo
  74. 6.13.1 Daiichi-Sankyo Company Information
  75. 6.13.2 Daiichi-Sankyo Business Overview
  76. 6.13.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  78. 6.13.5 Daiichi-Sankyo Recent Developments
  79. 6.14 Astellas
  80. 6.14.1 Astellas Company Information
  81. 6.14.2 Astellas Business Overview
  82. 6.14.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  84. 6.14.5 Astellas Recent Developments
  85. 6.15 Ardelyx
  86. 6.15.1 Ardelyx Company Information
  87. 6.15.2 Ardelyx Business Overview
  88. 6.15.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  90. 6.15.5 Ardelyx Recent Developments
  91. 6.16 Akebia
  92. 6.16.1 Akebia Company Information
  93. 6.16.2 Akebia Business Overview
  94. 6.16.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  96. 6.16.5 Akebia Recent Developments
7 North America by Country
  1. 7.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
  2. 7.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026)
  4. 7.1.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
  6. 7.2.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026)
  8. 7.2.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
  2. 8.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026)
  4. 8.1.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
  6. 8.2.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
  2. 9.1.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
  6. 9.2.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
  2. 10.1.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026)
  4. 10.1.3 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
  6. 10.2.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026)
  8. 10.2.3 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
  2. 11.1.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
  6. 11.2.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Analysis
  2. 12.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process
  7. 12.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
  10. 12.2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst